Amrutanjan Health Care (NSE:AMRUTANJAN) 5-Year EBITDA Growth Rate : 12.80% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care 5-Year EBITDA Growth Rate?

Amrutanjan Health Care's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.31.

During the past 12 months, Amrutanjan Health Care's average EBITDA Per Share Growth Rate was 16.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Amrutanjan Health Care was 35.10% per year. The lowest was -7.20% per year. And the median was 9.10% per year.

Competitive Comparison of Amrutanjan Health Care's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amrutanjan Health Care's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's 5-Year EBITDA Growth Rate falls into.

Amrutanjan Health Care 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Amrutanjan Health Care (NSE:AMRUTANJAN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Amrutanjan Health Care 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Amrutanjan Health Care (NSE:AMRUTANJAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

590006:India

Address

No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004

Website

https://www.amrutanjan.com

Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (NSE:AMRUTANJAN) Headlines

No Headlines